In vitro susceptibility of the Streptococcus milleri group to antimicrobial peptides

International Endodontic Journal

Volumn 41, Issue 7, 2008, Pages 586-592

  Bartie, K L ^a   Devine, D A ^a   Wilson, M J ^b   Lewis, M A O ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antimicrobial peptides; Endodontic; Infection susceptibility; Milleri; Streptococcus

Indexed keywords

ALPHA DEFENSIN; ANTIMICROBIAL CATIONIC PEPTIDE; CECROPIN; DEFENSIN 1; DEFENSIN 2; HISTATIN; INDOLICIDIN; MAGAININ DERIVATIVE; MASTOPARAN; PEPTIDE; WASP VENOM;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; HUMAN; IMMUNODIFFUSION; INSECT; MOLECULAR GENETICS; STREPTOCOCCUS MILLERI;

ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CECROPINS; HISTATINS; HUMANS; IMMUNODIFFUSION; INSECTS; MAGAININS; MOLECULAR SEQUENCE DATA; PEPTIDES; STREPTOCOCCUS MILLERI GROUP; WASP VENOMS;

EID: 45149089927     PISSN: 01432885     EISSN: 13652591     Source Type: Journal    
DOI: 10.1111/j.1365-2591.2008.01404.x     Document Type: Article

References (53)

1. Bantar C, Fernandez Canigia L, Relloso S, Lanza A, Bianchini H, Smayevsky J (1996) Species belonging to the "Streptococcus milleri" group: antimicrobial susceptibility and comparative prevalence in significant clinical specimens. Journal of Clinical Microbiology 34, 2020 2.
2. Basmadjian-Charles CL, Farge P, Bourgeois DM, Lebrun T (2002) Factors influencing the long-term results of endodontic treatment: a review of the literature. International Dental Journal 52, 81 6.
3. Bessalle R, Gorea A, Shalit I et al. (1993) Structure-function studies of amphiphilic antibacterial peptides. Journal of Medical Chemistry 36, 1203 9.
4. Bulet P, Stocklin R, Menin L (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunological Reviews 198, 169 84.
5. Chavez de Paz LE, Dahlén G, Molander A, Möller A, Bergenholtz G (2003) Bacteria recovered from teeth with apical periodontitis after antimicrobial endodontic treatment. International Endodontic Journal 36, 500 8.
6. Chen HC, Brown JH, Morell JL, Huang CM (1998) Synthetic magainin analogues with improved antimicrobial activity. FEBS Letters 236, 462 6.
7. Cluttterbuck AB, Cochrane CA, Dolman J, Percival SL (2007) Evaluating antibiotics for use in medicine using a poloxamer biofilm model. Annals of Clinical microbiology and antimicrobials 6, 2.
8. Cullor JS, Mannis MJ, Murphy CJ, Smith WL, Selsted ME, Reid TW (1990) In vitro antimicrobial activity of defensins against ocular pathogens. Archives of Ophthalmology 108, 861 4.
9. Dommisch H, Winter J, Acil Y, Dunshe A, Tiemann M, Jepsen S (2005a) Human beta-defensin (hBD-1, -2) expression in dental pulp. Oral Microbiology and Immunology 20, 163 6.
10. Dommisch H, Acil Y, Dunshe A, Winter J, Jepsen S (2005b) Differential gene expression of human beta-defensins (hBD-1, -2, -3) in inflammatory gingival diseases. Oral Microbiology Immunology 20, 186 90.
11. Elsbach P (2003) What is the real role of antimicrobial polypeptides that can mediate several other inflammatory responses? Jounral of Clinical Investigation 111, 1643 5.
12. Falla TJ, Hancock RE (1997) Improved activity of a synthetic indolicidin analog. Antimicrobial Agents and Chemotherapy 41, 771 5.
13. Fernandez RC, Weiss AA (1996) Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrobial Agents and Chemotherapy 40, 1041 3.
14. Fisher LE, Russell R (1993) The isolation and characterization of milleri group streptococci from dental periapical abscesses. Journal of Dental Research 72, 1191 3.
15. Ganz T, Selsted ME, Szklarek D et al. (1985) Defensins. Natural peptide antibiotics of human neutrophils. Journal of Clinical Investigation 76, 1427 35.
16. Gomes BPFA, Pinheiro ET, Gade-Neto CR et al. (2004) Microbiological examination of infected dental root canals. Oral Microbiology and Immunology 19, 71 6.
17. Groissman EA, Parra-Lopez C, Salcedo M, Lipps CJ, Heffron F (1992) Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proceedings National Academy Science USA 89, 11939 43.
18. Gunshefski L, Mannis MJ, Cullor JS et al. (1994) In vitro antimicrobial activity of Shiva-11 against ocular pathogens. Cornea 13, 237 42.
19. Halling SM (1996) The effects of magainin 2, cecropin, mastoparan and melittin on Brucella abortus. Veterinary Microbiology 51, 187 92.
20. Hancock RE, Falla T, Brown M (1995) Cationic bactericidal peptides. Advances in Microbial Physiology 37, 135 75.
21. Harder J, Bartels J, Christophers E, Schroder JM (1997) A peptide antibiotic from human skin. Nature 387, 861.
22. Helmerhorst EJ, Van't Hof W, Veerman EC, Simoons-Smit I, Nieuw I, Amerongen A (1997) Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochemistry Journal 326, 39 45.
23. Jacobs JA, Pietersen HG, Stobberingh EE, Soeters PB (1995) Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics. American Journal of Clinical Pathology 104, 547 53.
24. Jones DE, Bevins CL (1993) Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defence of the human bowel. FEBS Letters 315, 187 92.
25. Lee S, Mihara H, Aoyagi H, Kato T, Izumiya N, Yamasaki N (1986) Relationship between antimicrobial activity and amphiphilic property of basic model peptides. Biochimica & Biophysica Acta 862, 211 9.
26. Lee JY, Boman A, Sun CX et al. (1989) Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proceedings National Academy Science USA 86, 9159 62.
27. Lehrer RI, Rosenman M, Harwig SSSL, Jackson R, Eisenhauer P (1991) Ultrasensitive assays for endogenous antimicrobial polypeptides. Journal of Immunological Methods 137, 167 73.
28. Lewis MAO, MacFarlane TW, McGowan DA (1986) Quantitative bacteriology of acute dento-alveolar abscesses. Journal Medical Microbiology 21, 101 4.
29. Lewis MAO, MacFarlane TW, McGowan DA (1990) A microbiological and clinical review of the acute dentoalveolar abscess. British Journal of Oral Maxillofacial Surgery 28, 359 66.
30. Li ZQ, Merrifield RB, Boman IA, Boman HG (1988) Effects on electrophoretic mobility and antibacterial spectrum of removal of two residues from synthetic sarcotoxin IA and addition of the same residues to cecropin B. FEBS Letters 231, 299 302.
31. MacKay BJ, Denepitiya L, Iacono VJ, Krost SB, Pollock JJ (1984) Growth-inhibitory and bactericidal effects of human parotid salivary hisitine-rich polypeptides on Streptococcus mutans. Infection and Immunity 44, 695 701.
32. Mallow EB, Harris A, Salzman N et al. (1996) Human enteric defensins. Gene structure and developmental expression. Journal of Biological Chemistry 271, 4038 45.
33. Maloy WL, Kari UP (1995) Structure-activity studies on magainins and other host defense peptides. Biopolymers 37, 105 22.
34. McCray PB, Jr. Bentley L (1997) Human airway epithelia express a beta-defensin. American Journal of Respiratory and Cellular Molecular Biology 16, 343 9.
35. Mizukawa M, Sugiyama K, Ueno T, Mishima K, Takagi S, Sugahara T (1999) Defensin-1, an antimicrobial peptide present in the saliva of patients with oral diseases. Oral Diseases 5, 139 42.
36. Molander A, Reit C, Dahlen G, Kvist T (1998) Microbiological status of root-filled teeth with apical periodontitis. International Endodontic Journal 31, 1 7.
37. Moore AJ, Beazley WD, Bibby MC, Devine DA (1996) Antimicrobial activity of cecropins. Journal of Antimicrobial and Chemotherapy 37, 1077 89.
38. Piscitelli SC, Shwed J, Schreckenberger P, Danziger LH (1992) Streptococcus milleri group: renewed interest in an elusive pathogen. European Journal of Clinical Microbiology and Infectious Disease 11, 491 8.
39. Raj PA, Edgerton M, Levine MJ (1990) Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. Journal of Biological Chemistry 265, 3898 905.
40. Ramalingam K, Gururaja TL, Ramasubbu N, Levine MJ (1996) Stabilization of helix by side-chain interactions in histatin-derived peptides: role in candidacidal activity. Biochemistry and Biophysical Research Communications 225, 47 53.
41. Rôças IN, Jung IY, Lee CY, Siqueira JF (2004) Polymerase chain reaction identification of micro-organisms in previously root-filled teeth in a South Korea population. Journal of Endodontics 30, 504 8.
42. Stefanopoulos PK, Kolokotronis AE (2005) The clinical significance of anaerobic bacteria in acute orofacial odontogenic infections. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 98, 398 408.
43. Vianna ME, Horz H-P, Gomes BPFA, Conrads G (2005) Microarrays complement culture methods for identification of bacteria in endodontic infections. Oral Microbiology Immunology 20, 253 8.
44. Vianna ME, Horz HP, Gomes BP, Conrads G (2006) In vivo evaluation of microbial reduction after chemo-mechanical preparation of human root canals containing necrotic pulp tissue. International Endodontic Journal 39, 484 92.
45. Whiley RA, Hardie JM (1989) DNA-DNA hybridization studies and phenotypic characteristics of strains within the "Streptococcus milleri group" (1989). Journal of General Microbiology 135, 2623 33.
46. Whiley RA, Fraser H, Hardie JM, Beighton D (1990) Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains within the "Streptococcus milleri Group". Journal of Clinical Microbiology 28, 1497 501.
47. Whiley RA, Duke B, Hardie JM, Hall LMC (1995) Heterogenicity among 16S-23S rRNA intergenic spacers within the "Streptococcus milleri group". Journal of Clinical Microbiology 33, 1461 7.
48. Whiley RA, Hall LMC, Hardie JM, Beighton D (1997) Genotypic and phenotypic diversity within Streptococcus anginosus. International Journal of Systematic Bacteriology 47, 645 50.
49. Wieprecht T, Dathe M, Epand RM et al. (1997) Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry 36, 12869 80.
50. Willcox MDP, Knox KW (1990) Surface-associated properties of Streptococcus milleri group strains and their potential relation to pathogenesis. Journal of Medical Microbiology 31, 259 70.
51. Yasin B, Harwig SS, Lehrer RI, Wagar EA (1996) Susceptibility of Chlamydia trachomatis to protegrins and defensins. Infection and Immunity 64, 709 13.
52. Zhao C, Wang I, Lehrer RI (1996) Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Letters 396, 319 22.
53. Zuo Y, Xu T, Troxler RF, Li J, Driscoll J, Oppenheim FG (1995) Recombinant histatins: functional domain duplication enhances candidacidal activity. Gene 161, 87 91.